Inflammatory microenvironment in the initiation and progression of bladder cancer.

about

Inflammatory microenvironment in the initiation and progression of bladder cancer.

Item

http://www.wikidata.org/entity/Q46779353

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inflammatory microenvironment in the initiation and progression of bladder cancer.

@en

Inflammatory microenvironment in the initiation and progression of bladder cancer.

@nl

type

Item

label

Inflammatory microenvironment in the initiation and progression of bladder cancer.

@en

Inflammatory microenvironment in the initiation and progression of bladder cancer.

@nl

prefLabel

Inflammatory microenvironment in the initiation and progression of bladder cancer.

@en

Inflammatory microenvironment in the initiation and progression of bladder cancer.

@nl

P1476

Inflammatory microenvironment in the initiation and progression of bladder cancer.

@en

P2093

Liming Lei

http://www.w3.org/2001/XMLSchema#string

Liuxi Chen

http://www.w3.org/2001/XMLSchema#string

Tian Xie

http://www.w3.org/2001/XMLSchema#string

Xinbing Sui

http://www.w3.org/2001/XMLSchema#string

Xue Li

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for co-stimulation by the human CTLA-4/B7-2 complex

Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer

Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer

Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients

Metaplastic conditions of the bladder

Tumor-infiltrating dendritic cells in cancer pathogenesis

Nitric oxide in cancer metastasis

Trial watch: Dendritic cell-based anticancer therapy

Cancer-related inflammation

P304

93279-93294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.18632/ONCOTARGET.21565

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29190997

http://www.w3.org/2001/XMLSchema#string

P932

5696263

http://www.w3.org/2001/XMLSchema#string